Literature DB >> 15712078

Typhoid fever: a massive, single-point source, multidrug-resistant outbreak in Nepal.

Michael D Lewis1, Oralak Serichantalergs, Chittima Pitarangsi, Niphon Chuanak, Carl J Mason, Laxmi R Regmi, Prativa Pandey, Ranjan Laskar, Chandrika D Shrestha, Sarala Malla.   

Abstract

BACKGROUND: In the summer of 2002, a total of 5963 cases of typhoid fever were recorded in Bharatpur, Nepal (population, 92,214) during a 7-week period. A team from the Armed Forces Research Institute of Medical Sciences in Bangkok, Thailand, and the CIWEC Travel Medicine Clinic (Kathmandu, Nepal) assisted the Nepal National Public Health Laboratory (Kathmandu, Nepal) in the further investigation of this large, explosive febrile disease outbreak.
METHODS: Investigators conducted a thorough epidemiologic and laboratory investigation to assess the size and scope of the outbreak. In addition to subculturing of previously collected samples, blood samples were obtained from 100 febrile patients, and culture and susceptibility testing were done by standard laboratory methods. Pulsed field gel electrophoresis (PFGE) and plasmid analysis were done.
RESULTS: The majority of the isolates, including 1 from the municipal water supply, were multidrug resistant. The minimum inhibitory concentrations (MICs) of ciprofloxacin ranged from 0.19 microg/mL to 0.125 microg/mL. With use of PFGE, all isolates, including isolates from the water supply, showed an analytical similarity of 96%-100%. Multidrug-resistant isolates had a plasmid encoding for resistance, and those with resistance to nalidixic acid had a single-point mutation.
CONCLUSIONS: To the best of our knowledge, this outbreak is the largest single-point source outbreak of multidrug-resistant typhoid fever yet reported, and it was molecularly traced to the city's single municipal water supply. Isolates were uniformly resistant to nalidixic acid, there was a decrease in their susceptibility as measured by MIC of fluoroquinolones, and 90% of isolates obtained were resistant to >1 antibiotic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15712078     DOI: 10.1086/427503

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  33 in total

1.  Risk factors for typhoid fever in a slum in Dhaka, Bangladesh.

Authors:  P K Ram; A Naheed; W A Brooks; M A Hossain; E D Mintz; R F Breiman; S P Luby
Journal:  Epidemiol Infect       Date:  2006-08-08       Impact factor: 2.451

2.  Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia.

Authors:  Samuel Kariuki; Gunturu Revathi; John Kiiru; Doris M Mengo; Joyce Mwituria; Jane Muyodi; Agnes Munyalo; Yik Y Teo; Kathryn E Holt; Robert A Kingsley; Gordon Dougan
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

3.  Epidemiological characteristics and molecular typing of Salmonella enterica serovar Typhi during a waterborne outbreak in Eastern Anatolia.

Authors:  Y Bayram; H Güdücüoğlu; B Otlu; C Aypak; N C Gürsoy; H Uluç; M Berktaş
Journal:  Ann Trop Med Parasitol       Date:  2011-07

4.  The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines.

Authors:  Vu Dinh Thiem; Feng-Ying C Lin; Do Gia Canh; Nguyen Hong Son; Dang Duc Anh; Nguyen Duc Mao; Chiayung Chu; Steven W Hunt; John B Robbins; Rachel Schneerson; Shousun C Szu
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

Review 5.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

6.  High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi.

Authors:  Kathryn E Holt; Julian Parkhill; Camila J Mazzoni; Philippe Roumagnac; François-Xavier Weill; Ian Goodhead; Richard Rance; Stephen Baker; Duncan J Maskell; John Wain; Christiane Dolecek; Mark Achtman; Gordon Dougan
Journal:  Nat Genet       Date:  2008-07-27       Impact factor: 38.330

7.  High-throughput bacterial SNP typing identifies distinct clusters of Salmonella Typhi causing typhoid in Nepalese children.

Authors:  Kathryn E Holt; Stephen Baker; Sabina Dongol; Buddha Basnyat; Neelam Adhikari; Stephen Thorson; Anoop S Pulickal; Yajun Song; Julian Parkhill; Jeremy J Farrar; David R Murdoch; Dominic F Kelly; Andrew J Pollard; Gordon Dougan
Journal:  BMC Infect Dis       Date:  2010-05-31       Impact factor: 3.090

8.  Formative investigation of acceptability of typhoid vaccine during a typhoid fever outbreak in Neno District, Malawi.

Authors:  Lauren S Blum; Holly Dentz; Felix Chingoli; Benson Chilima; Thomas Warne; Carla Lee; Terri Hyde; Jacqueline Gindler; James Sejvar; Eric D Mintz
Journal:  Am J Trop Med Hyg       Date:  2014-07-07       Impact factor: 2.345

9.  Poor biofilm-forming ability and long-term survival of invasive Salmonella Typhimurium ST313.

Authors:  Girish Ramachandran; Komi Aheto; Mark E Shirtliff; Sharon M Tennant
Journal:  Pathog Dis       Date:  2016-05-23       Impact factor: 3.166

10.  Severe atovaquone-resistant Plasmodium falciparum malaria in a Canadian traveller returned from the Indian subcontinent.

Authors:  Thomas L Perry; Prativa Pandey; Jennifer M Grant; Kevin C Kain
Journal:  Open Med       Date:  2009-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.